Clinical Trial Update: Misoprostol for Secondary Prevention of Postpartum Hemorrhage at the Community Level in India [NA]

View source ↗

Summary

The clinical trial evaluated misoprostol for secondary prevention of postpartum hemorrhage at the community level in India and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Drugs mentioned

• MISOPROSTOL (Misoprostol)

Snippet

Sponsor: Gynuity Health Projects | Conditions: Postpartum Hemorrhage | NA | Status: COMPLETED